FERRACIN, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 7.309
EU - Europa 1.765
AS - Asia 1.735
SA - Sud America 119
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 10.945
Nazione #
US - Stati Uniti d'America 7.288
SG - Singapore 699
CN - Cina 633
UA - Ucraina 364
DE - Germania 363
IT - Italia 298
TR - Turchia 256
GB - Regno Unito 207
FI - Finlandia 156
SE - Svezia 114
PL - Polonia 107
BR - Brasile 105
ID - Indonesia 49
FR - Francia 29
HK - Hong Kong 27
BE - Belgio 26
NL - Olanda 24
RO - Romania 19
AT - Austria 18
CA - Canada 18
RU - Federazione Russa 14
VN - Vietnam 13
IR - Iran 10
CZ - Repubblica Ceca 9
KR - Corea 8
IN - India 7
LT - Lituania 7
IQ - Iraq 6
JP - Giappone 6
AR - Argentina 5
EC - Ecuador 3
EU - Europa 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
ZA - Sudafrica 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
MU - Mauritius 1
MX - Messico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.945
Città #
Fairfield 1.070
Woodbridge 983
Houston 593
Ashburn 476
Chandler 452
Jacksonville 436
Ann Arbor 419
Seattle 418
Santa Clara 355
Wilmington 343
Cambridge 331
Singapore 278
Izmir 184
Beijing 135
Nanjing 126
Ferrara 109
Warsaw 106
Princeton 100
Munich 95
San Diego 88
Boardman 74
Helsinki 59
New York 54
Shanghai 53
Los Angeles 50
Milan 49
Jakarta 47
Nanchang 42
Bremen 41
Falls Church 41
Dearborn 34
London 33
Hebei 28
Brussels 26
Shenyang 26
Changsha 25
Tianjin 25
Hong Kong 24
Jiaxing 23
Addison 21
Jinan 19
Mountain View 18
Timisoara 17
Norwalk 14
Toronto 14
Dong Ket 13
Hangzhou 12
Kunming 12
Falkenstein 11
Guangzhou 11
Ningbo 11
Nuremberg 11
Zhengzhou 11
Auburn Hills 10
Philadelphia 10
Redwood City 10
San Mateo 10
Tappahannock 10
Vienna 10
Washington 10
Brno 9
Chicago 9
Augusta 8
Bologna 8
Hefei 8
Orange 8
São Paulo 8
Frankfurt am Main 7
Kilburn 7
Taizhou 7
Des Moines 6
Jyväskylä 6
Verona 6
Changchun 5
Cleveland 5
Indiana 5
Monmouth Junction 5
Naples 5
Ardabil 4
Monte San Pietro 4
Monza 4
Ottawa 4
Acton 3
Belo Horizonte 3
Campo Grande 3
Chiswick 3
Goiânia 3
Harbin 3
Hounslow 3
Rio de Janeiro 3
San Giorgio Di Piano 3
Taipei 3
Tokyo 3
Albignasego 2
Alfenas 2
Amman 2
Amsterdam 2
Bishkek 2
Brasília 2
Colchester 2
Totale 8.301
Nome #
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 276
Absolute quantification of cell-free microRNAs in cancer patients 206
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 197
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 196
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 182
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 163
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 159
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 155
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines 154
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 154
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 150
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 145
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 144
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 142
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 139
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 139
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 137
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 136
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 135
Tumor suppressor functions of ARLTS1 in lung cancers 132
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 131
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 127
A microRNA signature of hypoxia 127
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 123
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 123
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 121
Extensive modulation of a set of microRNAs in primary glioblastoma 121
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 121
MicroRNA deregulation in human thyroid papillary carcinomas 121
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 120
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 120
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 119
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 118
Oncogenic role of miR-483-3p at the IGF2/483 locus 117
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 116
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 116
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 115
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 114
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 113
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 112
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 112
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 112
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 112
Micro-RNA profiling in kidney and bladder cancers 111
null 111
Espressione dei MicroRNA nei carcinomi mammari 110
MicroRNAs in cancer (an overview) 110
Principles of MicroRNA involvement in breast cancer 108
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome 108
The Role of Micro-RNAs in Rheumatic Diseases: An Update 108
Regulation of microRNA expression: the hypoxic component 107
Modulation of mismatch repair and genomic stability by miR-155 103
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 102
null 101
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells 101
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 100
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 100
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. 99
OncomiR detection in circulating body fluids: a PDMS microdevice perspective. 97
MicroRNAs as biomarker of Parkinson disease? Small but mighty. 96
null 96
MicroRNAs and Their Role in Cancer 95
null 94
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 94
null 94
null 93
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice 93
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 92
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 92
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 92
null 91
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 90
null 89
null 89
MicroRNAs: toward the clinic for breast cancer patients 89
null 89
null 88
null 84
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 84
null 81
Mutated beta-catenin evades a microRNA-dependent regulatory loop 81
Micro-markers: microRNAs in cancer diagnosis and prognosis 80
null 80
null 77
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 75
null 72
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy 67
MicroRNA coinvolti nello sviluppo del carcinoma epatocellulare. Identificazione delle proteine bersaglio. 67
Familial cancer associated with a polymorphism in ARLTS1 65
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 63
Hemostasis gene expression of the internal jugular and saphenous veins 63
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells 59
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 57
null 53
Progetto triennale AIRC (MFAG 2011). Titolo: Circulating microRNAs as cancer-specific biomarkers 52
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 44
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 42
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review 40
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas 37
A microRNA expression signature of human solid tumors defines cancer gene targets 36
Totale 10.763
Categoria #
all - tutte 52.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.399
Totale 54.820


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020367 0 0 0 0 0 0 0 0 0 226 79 62
2020/20211.441 128 119 87 154 61 145 66 146 44 171 203 117
2021/20221.191 54 107 107 31 56 74 78 57 39 84 113 391
2022/20231.039 113 77 35 155 160 160 40 76 119 11 47 46
2023/2024560 70 62 23 8 43 111 27 35 10 22 9 140
2024/20251.698 42 45 180 121 314 251 118 141 478 8 0 0
Totale 11.129